Phase III Randomized Trial Comparing Overall Survival After Photon Versus Proton Chemoradiotherapy For Inoperable Stage II-IIIb Nsclc
Posted Date: Sep 28, 2020
- Investigator: Emily Daugherty
- Specialties: Cancer, Lung Cancer, Oncology, Radiation Oncology
- Type of Study: Device
To compare the overall survival (OS) in patients with stage II-IIIB NSCLC after image guided, motion-managed photon radiotherapy (Arm 1) or after image guided, motion-managed proton radiotherapy (Arm 2) both given with concurrent platinum- based chemotherapy.
Untreated Histologically Or Cytologically Proven Diagnosis Of Non-Small Cell Lung Cancer Prior To Registration. Clinical Ajcc (7Th Ed.) Stage Ii-Iiib Medically Non-Operable Disease, Or Surgically Unresectable Disease, Or Patients Who Refuse Surgery; Patients Who Present With N2 Or N3 Disease And An Undetectable Nsclc Primary Tumor Also Are Eligible.
Proton Therapy, Lung Cancer, Radiation Therapy
For More Information:
Emily Daugherty, Md